HK1004677A1 - Antigenic preparation for treatment or prevention of helicobacter infection - Google Patents

Antigenic preparation for treatment or prevention of helicobacter infection

Info

Publication number
HK1004677A1
HK1004677A1 HK98103784A HK98103784A HK1004677A1 HK 1004677 A1 HK1004677 A1 HK 1004677A1 HK 98103784 A HK98103784 A HK 98103784A HK 98103784 A HK98103784 A HK 98103784A HK 1004677 A1 HK1004677 A1 HK 1004677A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
antigenic preparation
helicobacter infection
helicobacter
Prior art date
Application number
HK98103784A
Other languages
English (en)
Inventor
Christopher Vincent Doidge
Adrian Lee
Fiona Jane Buck
Elizabeth Pietrzykowski
Charles Alexander Quinn
Ian George Barr
Michael John Kleinig
Original Assignee
Csl Ltd
Univ New South Wales
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd, Univ New South Wales filed Critical Csl Ltd
Publication of HK1004677A1 publication Critical patent/HK1004677A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98103784A 1994-02-21 1998-05-04 Antigenic preparation for treatment or prevention of helicobacter infection HK1004677A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM3995A AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection
PCT/AU1995/000077 WO1995022563A1 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Publications (1)

Publication Number Publication Date
HK1004677A1 true HK1004677A1 (en) 1998-12-04

Family

ID=3778612

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103784A HK1004677A1 (en) 1994-02-21 1998-05-04 Antigenic preparation for treatment or prevention of helicobacter infection

Country Status (11)

Country Link
US (1) US6663873B2 (da)
EP (1) EP0804489B1 (da)
JP (1) JPH10500102A (da)
KR (1) KR100351534B1 (da)
AT (1) ATE222930T1 (da)
AU (2) AUPM399594A0 (da)
CA (1) CA2182274C (da)
DE (1) DE69527986T2 (da)
HK (1) HK1004677A1 (da)
NZ (2) NZ281146A (da)
WO (1) WO1995022563A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
HUT77574A (hu) * 1994-10-05 1998-06-29 Antex Biologics Inc. Eljárás fokozott antigénaktivitású Helicobacter sp. és azt tartalmazó vakcina előállítására
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
AU693679B2 (en) * 1995-04-21 1998-07-02 Csl Limited Protective helicobacter antigens
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
AU6583398A (en) * 1997-03-26 1998-10-20 Avant Immunotherapeutics, Inc. Polypeptides which immunoreact with polyclonal antisera against (h. pylori)
GB9715702D0 (en) * 1997-07-24 1997-10-01 Univ Bristol Bacterial isolate
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
JP4054681B2 (ja) * 2001-02-21 2008-02-27 デンカ生研株式会社 ヘリコバクター・ピロリを認識する抗体、およびヘリコバクター・ピロリを検出する方法
DE102004024674A1 (de) * 2004-05-18 2005-12-15 Wolfgang Lorenz Mittel und Verfahren zur Diagnose, Prophylaxe und Therapie von Bindegewebserkrankungen
JP5028627B2 (ja) 2005-08-05 2012-09-19 国立大学法人徳島大学 ＩｇＡ抗体の選択的産生からＩｇＡ及びＩｇＧ両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン
BR112015014991B1 (pt) 2013-01-17 2024-01-23 Janssen Pharmaceuticals, Inc Anticorpo específico para e. coli mdr, plasmídeo, cassete de expressão, célula hospedeira, método de produção do anticorpo, método para identificar um anticorpo candidato, preparação farmacêutica e de diagnóstico, epítopo, imunogênio e ácido nucleico utilizados
RU2724530C2 (ru) 2014-02-06 2020-06-23 Экс4 Фамасьютиклз (Остриэ) ГмбХ Выделенное антитело (варианты), способ получения антитела, выделенная нуклеиновая кислота, экспрессионная кассета (варианты), плазмида (варианты), клетка-хозяин, фармацевтический препарат, набор, способ лечения больного, подверженного риску или страдающего от инфекции e.coli, и способ диагностики определения инфекций e.coli
TWI715617B (zh) 2015-08-24 2021-01-11 比利時商葛蘭素史密斯克藍生物品公司 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
AR109621A1 (es) 2016-10-24 2018-12-26 Janssen Pharmaceuticals Inc Formulaciones de vacunas contra glucoconjugados de expec
KR102532707B1 (ko) 2019-03-18 2023-05-12 얀센 파마슈티칼즈, 인코포레이티드 대장균 o-항원 다당류의 바이오컨쥬게이트, 이의 제조 방법, 및 이의 사용 방법
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644121B2 (en) * 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
US5098755A (en) * 1990-11-21 1992-03-24 Tanquary Albert C Textured thermoplastic elastomeric film, articles comprising same, and method of making such textured thermoplastic elastomeric film and articles
MX9301706A (es) 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
WO1993022343A1 (en) * 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
NZ269124A (en) * 1993-07-27 1997-06-24 Csl Ltd Vaccine comprising helicobacter antigens and its use in treating such infections
US6406703B1 (en) * 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
US5840302A (en) * 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
US5997881A (en) * 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
NZ509127A (en) * 1998-06-19 2004-01-30 Merieux Oravax Use of LT (E. coli) and CT (cholera toxin) for inducing immune responses against helicobacter infection

Also Published As

Publication number Publication date
KR100351534B1 (ko) 2003-03-15
CA2182274A1 (en) 1995-08-24
KR970701209A (ko) 1997-03-17
US6663873B2 (en) 2003-12-16
CA2182274C (en) 2007-05-22
AU693864B2 (en) 1998-07-09
DE69527986D1 (de) 2002-10-02
WO1995022563A1 (en) 1995-08-24
AU1801195A (en) 1995-09-04
NZ329879A (en) 1999-10-28
DE69527986T2 (de) 2003-04-10
ATE222930T1 (de) 2002-09-15
EP0804489A4 (da) 1997-11-19
JPH10500102A (ja) 1998-01-06
NZ281146A (en) 1998-04-27
EP0804489B1 (en) 2002-08-28
EP0804489A1 (en) 1997-11-05
US20020122794A1 (en) 2002-09-05
AUPM399594A0 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
AUPM612494A0 (en) Treatment or prevention of helicobacter infection
HK1004677A1 (en) Antigenic preparation for treatment or prevention of helicobacter infection
GB2303854B (en) Helicobacter proteins and vaccines
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
AU1098400A (en) Invaplex from gram negative bacteria, method of purification and methods of use
AU1234697A (en) Streptococcus equi vaccine
NZ335050A (en) Helicobacter pylori live vaccine
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
EP0757556A4 (en) BACTERIN DE -i (BORRELIA BURGDORFERI)
BG102890A (en) Vaccine for mammals of the feline family containing chlamydia prittaci, and a method for its preparation
ZA891242B (en) 24r-scymnol,and preparation and use thereof
DE69615537D1 (en) Helicobacter pylori antigen
GR3019525T3 (en) Neuraminidase and galactose oxidase as vaccine adjuvant
CA2191440A1 (en) Treatment and prevention of helicobacter infection
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU2790095A (en) Thiopyridines for combating (helicobacter) bacteria
NZ331674A (en) Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection
EP0614364A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFECTIONS USING OPTICALLY PURE (S) -LOMEFLOXACIN.
AU8464398A (en) Urease based vaccine against (helicobacter) infection
MX9708226A (es) Vacunas que contienen una saponina y un esterol.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110217